论著

空间记忆检测与蒙特利尔认知评估筛查中国老年人群轻度认知障碍的效度比较

  • 王佳悦 ,
  • 熊文魁 ,
  • 姜玮贇 ,
  • 王健 ,
  • 曾乃燕 ,
  • 岳玲
展开
  • 1 上海交通大学医学院附属精神卫生中心老年精神心理科(上海交通大学阿尔茨海默病诊治中心)上海 200030
    2 上海浦东新区精神卫生中心老年精神科(同济大学附属心理卫生中心上海浦东新区心理咨询中心)上海 200124
    3 浙江玉安康瑞生物科技有限公司浙江 314100
    4 上海交通大学医学院病理生理学系上海 200025
曾乃燕 E-mail:zengny@shsmu.edu.cn
岳玲 E-mail:bellinthemoon@hotmail.com

收稿日期: 2026-01-31

  修回日期: 2026-03-10

  录用日期: 2026-03-11

  网络出版日期: 2026-04-25

基金资助

科技创新-2030“脑科学与类脑研究”重大项目(2022ZD0213100);上海市加强公共卫生体系建设三年行动计划优秀学科带头人(GWVI-11.2-XD24);2025科教兴医培育类项目科研课题-面上项目(PW2025A-08)

Comparison of validity between spatial memory test (SMT) and Montreal cognitive assessment (MoCA) for screening mild cognitive impairment in Chinese elderly population

  • WANG Jiayue ,
  • XIONG Wenkui ,
  • JIANG Weiyun ,
  • WANG Jian ,
  • ZENG Naiyan ,
  • YUE Ling
Expand
  • 1 Department of Geriatric Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine (Shanghai Jiao Tong University Alzheimer's Disease Diagnosis and Treatment Center), Shanghai 200030, China
    2 Department of Geriatric Psychiatry, Shanghai Pudong New Area Mental Health Center (Tongji University Affiliated Mental Health Center, Shanghai Pudong New Area Psychological Counseling Center), Shanghai 200124, China
    3 Yu Kang Biotechnology, Co., Ltd., Zhejiang 314100, China
    4 Department of Pathophysiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Received date: 2026-01-31

  Revised date: 2026-03-10

  Accepted date: 2026-03-11

  Online published: 2026-04-25

摘要

目的:探究空间记忆检测(spatial memory test,SMT)在中国老年人群中识别轻度认知障碍(mild cognitive impairment,MCI)的效能,并与蒙特利尔认知评估(Montreal cognitive assessment,MoCA)进行比较,为中国个体化筛查MCI提供依据。方法:本研究数据来自上海市老年人脑健康队列研究,选取自2023年1月至2024年1月期间连续入组的415名社区老年人,包括认知正常者(cognitively normal,NC)88例、主观认知下降(subjective cognitive decline, SCD)者188例和MCI患者139例。所有受试者均完成SMT与MoCA评估。以SCD、NC为对照组,以MCI为病例组,采用受试者操作特征曲线(receiver operating characteristic, ROC)曲线分析比较2种工具的筛查效能,进一步探讨SMT评分与不同神经心理学检验间的相关性,通过分层及交叉分析探讨年龄和教育水平对其筛查效能的影响。结果:SMT与MoCA均能较好地识别MCI,且SMT展现出更优的整体筛查效能。在区分SCD与MCI时,MoCA的ROC曲线的曲线下面积(area under the curve, AUC)略高于SMT(0.925比0.885),但SMT在国际常用截断值下(≤8分)具备更高的筛查特异度(91.06%)和阳性预测值(84.89%),整体准确率达(80.0%),优于不同截断值下MoCA的综合表现。相关性分析发现,SMT不仅与MoCA总分呈正相关(r=0.612,P<0.001),且与延迟记忆、视空间推理这些AD早期敏感认知领域密切相关(P均<0.01)。分层分析显示,在年龄≥75岁人群中SMT、MoCA区分SCD与MCI的AUC无差异(0.917比0.910,P=0.802);在教育程度>9年的人群中两者区分SCD与MCI效能相当(AUC:0.924比0.904,P=0.358);交叉分析进一步表明,仅在教育程度>9年且年龄≥75岁的亚组中,MoCA区分SCD与MCI(AUC:0.942比0.864, P<0.05)及NC与MCI(AUC:0.99比0.90, P<0.05)的效能略优于SMT。结论:SMT作为一种数字化早期认知障碍的筛查工具,其筛查MCI的整体效能优于MoCA,且具有高特异度、操作便捷等优势,更适用于社区大规模筛查及高龄人群快速初筛。

本文引用格式

王佳悦 , 熊文魁 , 姜玮贇 , 王健 , 曾乃燕 , 岳玲 . 空间记忆检测与蒙特利尔认知评估筛查中国老年人群轻度认知障碍的效度比较[J]. 诊断学理论与实践, 2026 , 25(02) : 165 -173 . DOI: 10.16150/j.1671-2870.2026.02.007

Abstract

Objective To evaluate the screening performance of the Spatial Memory Test (SMT) in identifying mild cognitive impairment (MCI) among the elderly population in China, and to compare it with the Montreal Cognitive Assessment (MoCA), in order to provide a foundation for individualized MCI screening in China. Methods The data for this study were derived from the Shanghai Elderly Brain Health Cohort Study, including 415 community-dwelling older adults consecutively enrolled from January 2023 to January 2024, comprising 88 cognitively normal (NC) individuals, 188 with subjective cognitive decline (SCD), and 139 individuals with mild cognitive impairment (MCI). All participants completed SMT and MoCA assessments. SCD and NC were served as the control groups and MCI as the case group, and receiver operating characteristic (ROC) curve analysis was employed to compare the screening performance of the two tools. Furthermore, the correlation between SMT scores and various neuropsychological tests was explored, and stratified and interaction analyses were conducted to examine the effects of age and education level on the screening performance of SMT. Results Both SMT and MoCA effectively identified MCI, with SMT demonstrating superior overall screening performance. When distingui-shing SCD from MCI, the area under the receiver operating characteristic curve (AUC) of MoCA was slightly higher than that of SMT (0.925 vs. 0.885). However, SMT showed higher specificity (91.06%) and positive predictive value (84.89%) at the commonly used international cutoff point (≤8), with an overall accuracy of 80.0%, outperforming MoCA across different cutoff values. Correlation analysis indicated that SMT was not only positively correlated with the total MoCA score (r=0.612, P<0.001), but also closely associated with cognitive domains sensitive to early AD, such as delayed recall and visuospatial reasoning (all P<0.01). Stratified analysis revealed that among individuals aged ≥75 years, the AUC for distinguishing SCD from MCI was comparable between SMT and MoCA (0.917 vs. 0.910, P=0.802); among those with education >9 years, the performance of the two tests in distinguishing SCD from MCI was similar (AUC: 0.924 vs. 0.904, P=0.358). Interaction analysis further indicated that only in the subgroup with education >9 years and age ≥75 years did MoCA slightly outperform SMT in distinguishing SCD from MCI (AUC: 0.942 vs. 0.864, P<0.05) and NC from MCI (AUC: 0.99 vs. 0.90, P<0.05). Conclusion As a digital screening tool for early cognitive impairment, SMT demonstrates superior overall performance compared to MoCA in screening for MCI, with advantages of high specificity and ease of use, and is more suitable for large-scale community screening and rapid preliminary assessment in the elderly population.

参考文献

[1] 首都医科大学宣武医院国家神经疾病医学中心, 中国疾病预防控制中心慢性非传染性疾病预防控制中心, 国家卫生健康委能力建设和继续教育中心, 等. 中国阿尔茨海默病蓝皮书(精简版)[J]. 中华医学杂志, 2024, 104(29):2701-2727.
  National Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University; National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention; National Health Commission Capacity Building and Continuing Education Center, et al. Blue paper on Alzheimer′s disease in China(simplified version)[J]. Natl Med J China, 2024, 104(29):2701-2727.
[2] 岳玲, 江叶昊. 阿尔茨海默病诊断和分期新标准:生物标志物引领的精准医疗时代[J]. 神经病学与神经康复学杂志, 2025, 21(1):1-5.
  YUE L, JIANG Y H. New diagnostic and staging criteria for Alzheimer's disease:the era of precision medicine led by biomarkers[J]. J Neurol Neurorehabil, 2025, 21(1):1-5.
[3] RABIN L A, SMART C M, AMARIGLIO R E. Subjective cognitive decline in preclinical Alzheimer’s disease[J]. Annu Rev Clin Psychol, 2017,13:369-396.
[4] SANFORD A M. Mild cognitive impairment[J]. Clin Geria-tr Med, 2017, 33(3):325-337.
[5] 马瑾瑾, 肖卫忠. 阿尔茨海默病早期诊断方法[J]. 中国临床研究, 2024, 37(7):1113-1119.
  MA J J, XIAO W Z. Early diagnosis of Alzheimer's di-sease[J]. Chin J Clin Res, 2024, 37(7):1113-1119.
[6] 初曙光, 王刚. 淀粉样蛋白相关影像学异常:一种与阿尔茨海默病治疗相关的具有影像学特征和诊断特异性的MRI表现[J]. 神经病学与神经康复学杂志, 2025, 21(1):6-11.
  CHU S G, WANG G. Amyloid-related imaging abnormalities:an MRI manifestation associated with Alzheimer's disease-targeted therapy with imaging characteristics and diagnostic specificit[J]. J Neurol Neurorehabil, 2025, 21(1):6-11.
[7] JIA X, WANG Z, HUANG F, et al. A comparison of the Mini-mental state examination (MMSE) with the Montreal cognitive assessment (MoCA) for mild cognitive impairment screening in Chinese middle-aged and older population: A cross-sectional study[J]. BMC Psychiatry, 2021, 21(1):485.
[8] AMRO I, AL HAMADI A M, EL SALEM A A, et al. Population-based norms for the Montreal cognitive assessment in Arab adults[J]. Brain Behav, 2025, 15(2):e70287.
[9] 夏安琪, 李军, 岳玲, 等. 蒙特利尔认知评估量表在中国社区老人中的应用[J]. 上海交通大学学报(医学版), 2021, 41(12):1661-1667.
  XIA A Q, LI J, YUE L, et al. Application of Montreal cognitive assessment scale to the elderly in Chinese community[J]. J Shanghai Jiao Tong Univ(Med Sci), 2021, 41(12):1661-1667.
[10] ISLAM N, HASHEM R, GAD M, et al. Accuracy of the Montreal Cognitive Assessment tool for detecting mild cognitive impairment: A systematic review and meta-analysis[J]. Alzheimers Dement, 2023, 19(7):3235-3243.
[11] VORA N, PATEL P, MARSOOL M D M, et al. Atypical Alzheimer’s dementia: Addressing the subtypes, epide-miology, atypical presentations, diagnostic biomarkers, and treatment updates[J]. Dis a Mon, 2025, 71(5):101863.
[12] SANTAGATA F, CAPPA S F, PRESTA R, et al. Visuospatial impairment in dementia: A new index to improve the clinical diagnosis of Alzheimer’s disease[J]. Aging Clin Exp Res, 2025, 37(1):127.
[13] WANG H, FAN Z, SHI C, et al. Consensus statement on the neurocognitive outcomes for early detection of mild cognitive impairment and Alzheimer dementia from the Chinese Neuropsychological Normative (CN-NORM) Project[J]. J Glob Health, 2019, 9(2):020320.
[14] JESSEN F, AMARIGLIO R E, VAN BOXTEL M, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease[J]. Alzheimers Dement, 2014, 10(6):844-852.
[15] PETERSEN R C, DOODY R, KURZ A, et al. Current concepts in mild cognitive impairment[J]. Arch Neurol, 2001, 58(12):1985.
[16] ZHANG S, QIU Q, QIAN S, et al. Determining appropriate screening tools and cutoffs for cognitive impairment in the Chinese elderly[J]. Front Psychiatry, 2021,12:773281.
[17] MICHALLAT-BRAGG G, BENNETT M, FLEWITT B I, et al. Exploring the sensitivity of episodic and spatial memory tests to healthy and pathological cognitive aging[J]. Front Aging Neurosci, 2025,17:1547834.
[18] HARTLEY T, BIRD C M, CHAN D, et al. The hippocampus is required for short-term topographical memory in humans[J]. Hippocampus, 2007, 17(1):34-48.
[19] HONG Y, ZENG X, ZHU C W, et al. Evaluating the Beijing version of Montreal cognitive assessment for identification of cognitive impairment in monolingual Chinese American older adults[J]. J Geriatr Psychiatry Neurol, 2022, 35(4):586-593.[LinkOut]
[20] PARRA-RODRíGUEZ L, SILVA-PEREYRA J, SáNCHEZ-GARCíA S, et al. Normative data for the Montreal cognitive assessment (MoCA) in Mexican adults: A regression-based approach[J]. Diagnostics, 2025, 15(22):2920.
[21] 肖世富, 徐巍, 姚培芬. 世界卫生组织老年认知功能评价成套神经心理测验的临床初步应用[J]. 中华精神科杂志, 1999, 32(4):230.
  XIAO S F, XV W, YAO P F. The preliminary clinical use of the World Health Organization battery of cognitive assessment instruments for elderly[J]. Chin J Psychiatry, 1999, 32(4):230.
[22] YOSHIMURA T, OSAKA M, OSAWA A, et al. The classical backward digit span task detects changes in working memory but is unsuitable for classifying the severity of dementia[J]. Appl Neuropsychol Adult, 2023, 30(5):528-534.
[23] LLINàS-REGLà J, VILALTA-FRANCH J, LóPEZ-POUSA S, et al. The trail making test: Association with other neuropsychological measures and normative values for adults aged 55 years and older from a Spanish-speaking population-based sample[J]. Assessment, 2017, 24(2):183-196.
[24] CAI Y, YANG T, YU X, et al. The alternate-form reliabi-lity study of six variants of the brief visual-spatial memory test-revised and the Hopkins verbal learning test-revised[J]. Front Public Health, 2023,11:1096397.
[25] CHEN K L, XU Y, CHU A Q, et al. Validation of the Chinese Version of Montreal cognitive assessment basic for screening mild cognitive impairment[J]. J Am Geriatr Soc, 2016, 64(12):e285-e290.
[26] SONG C S, LEE H S, CHUN B Y. Comparison of Montreal cognitive assessment in Korean version for predic-ting mild cognitive assessment in 65-year and over indi-viduals[J]. Occup Ther Int, 2022,2022:4108434.
[27] CLASSON E, VAN DEN HURK W, LYTH J, et al. Montreal cognitive assessment: Normative data for cognitively healthy Swedish 80- to 94-year-olds[J]. J Alzheimers Dis, 2022, 87(3):1335-1344.
[28] CHAN D, GALLAHER L M, MOODLEY K, et al. The 4 mountains test: A short test of spatial memory with high sensitivity for the diagnosis of pre-dementia Alzheimer’s disease[J]. J Vis Exp, 2016,116:54454.
[29] IWATSUBO T, SPERLING R A, ALGECIRAS-SCHIMNICH A, et al. Modernizing diagnosis of Alzheimer's disease: A review of global trends and Asia-specific perspectives[J]. Alzheimers Dement, 2025, 21(8):e70536.
文章导航

/